Clinical trial
Reduction of Symptomatic Ventricular Premature Beats With Ranolazine
NCT01996618 is registered in ClinicalTrials.gov with Walter Reed National Military Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Reduction of Symptomatic Ventricular Premature Beats With Ranolazine
- Lead sponsor
- Walter Reed National Military Medical Center
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- January 31, 2014
- Completion date
- July 31, 2016
- Enrollment
- 72 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
premature ventricular beats